Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardiometabolic Features of Polycystic Ovary Syndrome: Role of Androgens
Licy L. Yanes Cardozo, Damián G. Romero, Jane F. Reckelhoff
Physiology (2017) Vol. 32, Iss. 5, pp. 357-366
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

The effects of probiotic and selenium co-supplementation on parameters of mental health, hormonal profiles, and biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome
Mehri Jamilian, Shirin Mansury, Fereshteh Bahmani, et al.
Journal of Ovarian Research (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 119
Obesity and cardiovascular disease in women
Camila Manrique‐Acevedo, Bhavana Chinnakotla, Jaume Padilla, et al.
International Journal of Obesity (2020) Vol. 44, Iss. 6, pp. 1210-1226
Open Access | Times Cited: 94
Oxidative stress in polycystic ovary syndrome: a case- control study
Syeda Samira Azim, Zeba Haque, Sadaf Khan, et al.
Journal of the Pakistan Medical Association (2024) Vol. 74, Iss. 2, pp. S2-S7
Open Access | Times Cited: 4
Spaceflight-related ocular changes
Scott M. Smith, Sara R. Zwart
Current Opinion in Clinical Nutrition & Metabolic Care (2018) Vol. 21, Iss. 6, pp. 481-488
Closed Access | Times Cited: 38
Associations Between Serum Magnesium Concentrations and Polycystic Ovary Syndrome Status: a Systematic Review and Meta-analysis
Maedeh Babapour, Hamed Mohammadi, Maryam Kazemi, et al.
Biological Trace Element Research (2020) Vol. 199, Iss. 4, pp. 1297-1305
Closed Access | Times Cited: 32
Impact of SGLT-2 Inhibition on Cardiometabolic Abnormalities in a Rat Model of Polycystic Ovary Syndrome
Jacob E. Pruett, Edgar D. Torres Fernandez, Steven Everman, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 5, pp. 2576-2576
Open Access | Times Cited: 31
MicroRNA-21 ablation exacerbates aldosterone-mediated cardiac injury, remodeling, and dysfunction
Maryam Syed, Jana P. Ball, Keisa W. Mathis, et al.
AJP Endocrinology and Metabolism (2018) Vol. 315, Iss. 6, pp. E1154-E1167
Open Access | Times Cited: 31
Clinical, hormonal and metabolic parameters in women with PCOS with different combined oral contraceptives (containing chlormadinone acetate versus drospirenone)
Agnieszka Podfigurna, Błażej Męczekalski, Felice Petraglia, et al.
Journal of Endocrinological Investigation (2019) Vol. 43, Iss. 4, pp. 483-492
Open Access | Times Cited: 24
Hypertension Risk in Young Women With Polycystic Ovary Syndrome: A Nationwide Population-Based Cohort Study
Cheng-Hsuan Wu, Lu‐Ting Chiu, Yu‐Jun Chang, et al.
Frontiers in Medicine (2020) Vol. 7
Open Access | Times Cited: 23
SARS-CoV-2 Viral Entry Proteins in Hyperandrogenemic Female Mice: Implications for Women with PCOS and COVID-19
Alexandra M. Huffman, Samar Rezq, Jelina Basnet, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4472-4472
Open Access | Times Cited: 18
Obesity-associated cardiometabolic complications in polycystic ovary syndrome: The potential role of sodium-glucose cotransporter-2 inhibitors
Jacob E. Pruett, Damián G. Romero, Licy L. Yanes Cardozo
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 7
Insights Into the Cardiomodulatory Effects of Sex Hormones: Implications in Transgender Care
Noha M. Shawky, Jane F. Reckelhoff, Barbara T. Alexander, et al.
Hypertension (2023) Vol. 80, Iss. 9, pp. 1810-1820
Open Access | Times Cited: 7
Is it useful to measure DHEAS levels in PCOS?
Hélène Boucher, Geoffroy Robin, L. Ribière, et al.
Annales d Endocrinologie (2024) Vol. 85, Iss. 2, pp. 95-99
Closed Access | Times Cited: 2
Combined Oral Contraceptive Effects on Low-Grade Chronic Inflammatory Mediators in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
Sebastião Freitas de Medeiros, Matheus Antônio Souto de Medeiros, Nayara de Souza Santos, et al.
International Journal of Inflammation (2018) Vol. 2018, pp. 1-13
Open Access | Times Cited: 21
A Model Combining Testosterone, Androstenedione and Free Testosterone Index Improved the Diagnostic Efficiency of Polycystic Ovary Syndrome
Wanwan Yi, Mengyu Zhang, XueYu Yuan, et al.
Endocrine Practice (2023) Vol. 29, Iss. 8, pp. 629-636
Closed Access | Times Cited: 6
Long-Lasting Androgen-Induced Cardiometabolic Effects in Polycystic Ovary Syndrome
Edgar D. Torres Fernandez, Kristen V. Adams, Maryam Syed, et al.
Journal of the Endocrine Society (2018) Vol. 2, Iss. 8, pp. 949-964
Open Access | Times Cited: 18
Research Progress on the Effect of Epilepsy and Antiseizure Medications on PCOS Through HPO Axis
Shuang Li, Linhai Zhang, Nian Wei, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 14
Sodium-Glucose Cotransporter-2 Inhibition Benefits in Cardiorenal Risk in Men and Women
Jacob E. Pruett, Seth T. Lirette, Damián G. Romero, et al.
Journal of the Endocrine Society (2022) Vol. 7, Iss. 2
Open Access | Times Cited: 9
Cardiovascular disease risk in offspring of polycystic ovary syndrome
Noha M. Shawky
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 8
Dyslipidaemia in women with polycystic ovary syndrome referred to a teaching hospital in Cape Town, South Africa
A. David Marais, Anne Hoffman, Diane Mary Blackhurst, et al.
Journal of Neuroendocrinology (2024) Vol. 36, Iss. 10
Open Access | Times Cited: 1
MicroRNA-21 modulates brown adipose tissue adipogenesis and thermogenesis in a mouse model of polycystic ovary syndrome
Samar Rezq, Alexandra M. Huffman, Jelina Basnet, et al.
Biology of Sex Differences (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Androgens, the kidney, and COVID-19: an opportunity for translational research
Licy L. Yanes Cardozo, Samar Rezq, Jacob E. Pruett, et al.
AJP Renal Physiology (2021) Vol. 320, Iss. 2, pp. F243-F248
Open Access | Times Cited: 6
Hyperandrogenism Protects Against High Blood Pressure by Nongenomic Mechanisms and Obesity Causes Hypertension in Females with Polycystic Ovary Syndrome
Mercedes Perusquı́a, Nieves Herrera, Jaime Jasso-Kamel, et al.
Endocrine Research (2023) Vol. 48, Iss. 4, pp. 101-111
Closed Access | Times Cited: 2
Adrenal Androgen Predictive Effects on Clinical and Metabolic Abnormalities of Polycystic Ovary Syndrome
Sebastião Freitas de Medeiros, Bruna Barcelo Barbosa, Matheus Antônio Souto de Medeiros, et al.
Revista Brasileira Ginecologia e Obstetrícia (2022) Vol. 44, Iss. 02, pp. 142-153
Open Access | Times Cited: 4
Management of cardiometabolic complications in polycystic ovary syndrome: Unmet needs
Licy L. Yanes Cardozo, Damián G. Romero
The FASEB Journal (2021) Vol. 35, Iss. 11
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top